Sponsor Pipeline

Alfasigma S.p.A. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
3
Recruiting
5
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 3
5
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07554495 Safety, Tolerability, Pharmacokinetics, and Efficacy of Filgotinib for the Treatment of… Polyarticular Course Juvenile Idiopathic Arthritis Recruiting
NCT07553182 OLE Study With Filgotinib in JIA Juvenile Idiopathic Arthritis (JIA) Recruiting
NCT06865417 A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative… Ulcerative Colitis Recruiting
NCT05785611 A Study Evaluating the Effect of Filgotinib in Participants With Active Axial… Axial Spondyloarthritis Active, Not Recruiting
NCT02914535 Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis Ulcerative Colitis Active, Not Recruiting
Not specified
NCT04871919 Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis Rheumatoid Arthritis Active, Not Recruiting
NCT05817942 Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants… Ulcerative Colitis Active, Not Recruiting
Disease Areas
Get alerts when Alfasigma S.p.A.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free